A new FGFR inhibitor disrupts the TGF‐β1‐induced fibrotic process

Pulmonary fibrosis (PF) is chronic and irreversible damage to the lung characterized by fibroblast activation and matrix deposition. Although recently approved novel anti‐fibrotic agents can improve the lung function and survival of patients with PF, the overall outcomes remain poor. In this study,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cell Mol Med
Main Authors: Kim, Mi‐Hyoung, Jung, Seung‐Youn, Song, Kyung‐Hee, Park, Jeong‐In, Ahn, Jiyeon, Kim, Eun‐Ho, Park, Jong Kuk, Hwang, Sang‐Gu, Woo, Hee‐Jong, Song, Jie‐Young
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6933341/
https://ncbi.nlm.nih.gov/pubmed/31692229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14793
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados